Zacks Investment Research
18 Jun 2026, 17:51 UTC · 14w ago
Verdict
Headline takes no side. We score PEN +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Penumbra, Inc. (PEN) received the CE Mark in Europe for its THUNDERBOLT computer-assisted vacuum thrombectomy technology.
More positive than 79% of claims this week
Zacks Consensus Estimates for 2026 project a 32.3% year-over-year increase in earnings and 13.3% revenue growth for Penumbra.
So whatStrong projected growth rates typically support a higher valuation and positive investor sentiment.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 66% of claims this week
Penumbra's international revenues grew 16.5% year-over-year in Q1 2026, accounting for 20.9% of total revenues.
More positive than 53% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
Company received CE Mark in Europe for its THUNDERBOLT technology, which is expected to boost market sentiment and diversify revenue.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
16h ago
+0.9%
Price agrees with the score
$318.89 vs $316.16 close before publication (Jun 17) · not market-adjusted
PEN chart →
